[ GeneMind · No Referral Needed · Physician-Ready Report ]

Mental Health DNA Test — End the Medication Guessing Game

Patients try an average of 3.4 psychiatric medications before one works. That isn’t bad luck — it’s genetics. GeneMind maps the genes that decide how you metabolize antidepressants, anxiolytics, and mood stabilizers, so your next prescription is the right one.

Get GeneMind — $349 or $89/mo The Genes Behind It
By Dr. Michael Okonkwo, Chief Medical OfficerMedically reviewed by Shawn Desai, MD, PhD, Lab Director & Medical DirectorAugust 2026
[ 95+ Genes · 6 Categories ][ CYP2D6 · CYP2C19 · SLC6A4 ][ Results In ~72 Hours ]

Why Psychiatric Medications Fail

Brain imagery representing mental health genetics and psychiatric medication response

Up to 99% of people carry at least one pharmacogenomic variant that changes how psychiatric medications work in their body. Three gene families do most of the damage when prescribing ignores them:

CYP2D6

The Metabolism Gatekeeper

Controls how your liver processes fluoxetine, paroxetine, venlafaxine, and dozens more. Poor metabolizers get side effects at standard doses; ultra-rapid metabolizers clear the drug before it can work.

CYP2C19

The SSRI Decider

Governs citalopram, escitalopram, and sertraline — among the most prescribed antidepressants in the US. If you’re an ultra-rapid or poor metabolizer, standard doses either do nothing or cause immediate side effects.

SLC6A4

The Serotonin Baseline

The serotonin transporter gene (5-HTTLPR) influences how your brain responds to SSRIs at the receptor level — shaping both response and side-effect sensitivity before metabolism even enters the picture.

The result of ignoring these genes: months per failed medication, an average of 3.4 medications tried before one works, and patients who conclude treatment “just doesn’t work for me.” It usually does — the dose and the drug were just wrong for their genome.

What GeneMind Tests — 95+ Genes, 6 Categories

[ CLIA-Certified · CPIC/DPWG-Aligned ]
Category 1

Medication Metabolism

CYP2D6, CYP2C19 and related pharmacogenes — your metabolizer phenotype for antidepressants, anxiolytics, and mood stabilizers.

Category 2

Serotonin Pathways

SLC6A4 and the serotonin system — SSRI response likelihood and side-effect sensitivity.

Category 3

Dopamine & Mood

Dopaminergic pathway variants linked to motivation, reward processing, and mood regulation.

Category 4

Stress Response

HPA-axis and cortisol-regulation genetics — how your body mounts and resolves the stress response.

Category 5

Cognitive Function

Variants affecting focus, memory, and cognitive performance under stress.

Category 6

Sleep Architecture

Circadian and sleep-quality genetics — often the hidden variable in treatment resistance.

Need broader medication coverage? GenePGx extends your profile to 230+ genes and 700+ medications — cardiology, pain, oncology, and more. Both are included in the membership. Coming from GeneSight? See our GeneSight alternative comparison →

A Real GeneMind Story

[ CYP2C19 Ultra-Rapid Metabolizer ]

“I tried four different SSRIs over three years. Each one either did nothing or made me feel worse within days. My psychiatrist was running out of ideas and I was starting to think therapy just didn’t work for me. GeneMind showed I’m a CYP2C19 ultra-rapid metabolizer — my liver processes SSRIs so quickly they never reach therapeutic levels in my blood. My psychiatrist switched to an SNRI that uses a different metabolic pathway. Within six weeks I felt better than I had in a decade.”

GeneMind Patient · Result: CYP2C19 Ultra-Rapid Metabolizer · Shared With Permission

Three years of trial and error, explained by a single variant. That is what a mental health DNA test is for. Individual results vary — GeneMind informs prescribing decisions; it does not replace your clinician.

One Membership. Every Answer.

[ GeneMind + 10 More Tests ]

GeneMind is $349 one-time — or included with the Gene Matrix Membership at $89/month ($59/mo billed annually, $712/yr) alongside all 10 other tests, including GenePGx’s 700+-medication pharmacogenomics panel. Quarterly AI reinterpretation keeps your results current as CPIC guidelines evolve. Swab at home with an FDA-cleared collection device, results in 5–7 days (48-hour priority available) at up to 99.9% analytical accuracy, counselor included. 30-day money-back guarantee.

Start Membership — $89/mo GeneMind Test Details
[ $349 One-Time Or $89/mo ][ HSA / FSA Eligible ][ Counselor Included ]

Mental Health DNA Testing — FAQs

Because prescribing is still trial and error while metabolism is genetic. Variants in CYP2D6 and CYP2C19 determine how fast your liver processes antidepressants — ultra-rapid metabolizers clear SSRIs before they reach therapeutic levels, while poor metabolizers get side effects at standard doses. SLC6A4 variants affect baseline serotonin transport. Up to 99% of people carry at least one pharmacogenomic variant affecting psychiatric medication metabolism, and patients try an average of 3.4 medications before finding one that works.

GeneMind analyzes 95+ genes across 6 categories: antidepressant and anxiolytic metabolism (CYP2D6, CYP2C19), serotonin pathways (SLC6A4 and related genes), dopamine and mood regulation, stress response, cognitive function, and sleep architecture. Results map your complete psychiatric pharmacogenomic profile with CPIC/DPWG-aligned guidance your psychiatrist can act on.

No. Unlike GeneSight, which is clinician-ordered only as of 2026, Gene Matrix GeneMind is direct-to-consumer: order online, swab at home with an FDA-cleared collection device, and receive a physician-ready report in 5–7 days (48-hour priority processing available). Bring it to any psychiatrist — the report is formatted for clinical use with metabolizer phenotypes and medication guidance.

GeneMind is $349 one-time with a published price, or included with the Gene Matrix Membership at $89/month ($59/month billed annually, $712/yr) along with all 10 other genetic tests — including GenePGx, which extends medication coverage to 700+ drugs. HSA/FSA cards are accepted, and every plan includes a 30-day money-back guarantee.

Yes — Gene Matrix reports are physician-ready: CLIA-certified lab results, CPIC/DPWG-aligned interpretations, and specific metabolizer phenotypes formatted for prescribers. Psychiatrists routinely incorporate pharmacogenomic results when selecting antidepressants, anxiolytics, and mood stabilizers. A board-certified genetic counselor session is included with every positive result to help you prepare.

No — and any test claiming otherwise should not be trusted. GeneMind does not diagnose mental health conditions. It reveals how your genetics affect medication metabolism, neurotransmitter pathways, and stress response, so you and your clinician can make better-informed treatment decisions. Diagnosis remains a clinical process with a qualified professional.

Dr. Michael Okonkwo
Chief Medical Officer · Gene Matrix
Medically reviewed by Shawn Desai, MD, PhD, Lab Director & Medical Director · August 2026